CME vs CTKB · P/E 22, rev $3.59B vs rev $92.3M
CME Group Inc (CME) versus Cytek Biosciences Inc (CTKB) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported CTKB revenue for 2026-06-30 was $92.3M. Net income was -$31.0M. CTKB currently screens at market cap $421.8M.
CME currently screens at market cap $91.25B and trailing P/E 21.9. CTKB currently screens at market cap $421.8M.
Not investment advice. Open the CME and CTKB stock pages for the full models.
Not investment advice.